Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1995 | 06-1995 | 03-1995 | 12-1994 | 09-1994 | |
| Sales | 4,057 | 4,061 | 4,117 | 4,565 | 2,994 |
| Cost of Goods | 0 | 0 | 0 | -7,084 | 0 |
| Gross Profit | 4,057 | 4,061 | 4,117 | 13,222 | 2,994 |
| Operating Expenses | 6,734 | 6,498 | 5,595 | 12,897 | 5,491 |
| Operating Income | -2,677 | -2,437 | -1,478 | -1,332 | -2,497 |
| Interest Expense | 0 | 0 | 1 | 0 | 2 |
| Pre-tax Income | -2,677 | -2,437 | -1,479 | -1,332 | -2,499 |
| Net Income Continuous | -2,676 | -2,438 | -1,479 | -1,332 | -2,499 |
| Net Income | $-2,676 | $-2,438 | $-1,479 | $-1,332 | $-2,499 |
| EPS Basic Total Ops | -0.04 | -0.04 | -0.03 | -0.02 | -0.05 |
| EPS Basic Continuous Ops | -0.04 | -0.04 | -0.02 | -0.02 | -0.04 |
| EPS Diluted Total Ops | -0.04 | -0.04 | -0.03 | -0.02 | -0.05 |
| EPS Diluted Continuous Ops | -0.04 | -0.04 | -0.02 | -0.02 | -0.04 |
| EBITDA(a) | $-2,677 | $-2,437 | $-1,478 | $-1,332 | $-2,497 |